Table 1

Preclinical treatments

TreatmentDuration of release (days)Bupivacaine concentration
(mg/mL)
Meloxicam concentration
(mg/mL)
Preclinical
dose
(mL)
ER-B-6D617601.8
ER-B/M-6D6176351.8
ER-B-3D32903.4
ER-M-3D301.81.8
ER-B/M-3D3291.83.4
Normal salineN/AN/AN/A1.8
Liposomal bupivacaine31308.0
  • 3D, 3-day formulation; 6D, 6-day formulation; B, bupivacaine; ER, extended release; M, meloxicam; N/A, not applicable.